UPDATE 6-Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'
Wed, 29 Apr 2020 21:46:00 UTCNews Agency:
The top U.S. infectious disease
official said Gilead Sciences Inc's experimental antiviral drug
remdesivir will become the standard of care for COVID-19 after
early results from a key clinical trial on Wednesday showed it
helped patients recover more quickly from the illness caused by
Click here for FULL Story on Reuters